# Clustering Approach 5 : MRNASEQ_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.91828216102747	Range of duration = 0.03 to 26.99, nDeath = 4, nCensor = 16
2	AGE	t-test	0.302655274764778	Range of values = 24 to 90, Mean = 60.7083, StdDev = 15.8594, nMissing = 3
3	PRIMARY.SITE.OF.DISEASE	Chi-square test	0.468271040680254	nTypes = 3 (DISTANT METASTASIS/PRIMARY TUMOR/REGIONAL CUTANEOUS OR SUBCUTANEOUS TISSUE (INCLUDES SATELLITE AND IN-TRANSIT METASTASIS)), nPatients = 2/23/2
4	GENDER	Fisher's exact test	0.231121281464531	nTypes = 2 (FEMALE/MALE), nPatients = 9/18
5	LYMPH.NODE.METASTASIS	Chi-square test	0.516832036001561	nTypes = 8 (N0/N1A/N1B/N2A/N2B/N2C/N3/NX), nPatients = 14/1/1/1/3/1/2/3, nMissing = 1
6	TUMOR.STAGECODE	t-test	NA	Range of values = Inf to -Inf, Mean = NaN, StdDev = NA, nMissing = 27
7	NEOPLASM.DISEASESTAGE	Chi-square test	0.324739788603879	nTypes = 8 (STAGE IB/STAGE II/STAGE IIA/STAGE IIC/STAGE IIIA/STAGE IIIB/STAGE IIIC/STAGE IV), nPatients = 1/1/1/14/1/3/3/1, nMissing = 2
